These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26672094)

  • 1. Evidence of Extrapancreatic Glucagon Secretion in Man.
    Lund A; Bagger JI; Wewer Albrechtsen NJ; Christensen M; Grøndahl M; Hartmann B; Mathiesen ER; Hansen CP; Storkholm JH; van Hall G; Rehfeld JF; Hornburg D; Meissner F; Mann M; Larsen S; Holst JJ; Vilsbøll T; Knop FK
    Diabetes; 2016 Mar; 65(3):585-97. PubMed ID: 26672094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the role of the gut in diabetic hyperglucagonaemia.
    Lund A
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreas: Extrapancreatic glucagon in humans.
    Thomas H
    Nat Rev Endocrinol; 2016 Feb; 12(2):63. PubMed ID: 26729039
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
    Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudo-hyperglucagonemia was observed in pancreatectomized patients when measured by glucagon sandwich enzyme-linked immunosorbent assay.
    Kobayashi M; Waki H; Nakayama H; Miyachi A; Mieno E; Hamajima H; Goto M; Yamada K; Yamauchi T; Kadowaki T; Kitamura T
    J Diabetes Investig; 2021 Feb; 12(2):286-289. PubMed ID: 32548980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes.
    Hare KJ; Vilsbøll T; Holst JJ; Knop FK
    Am J Physiol Endocrinol Metab; 2010 Apr; 298(4):E832-7. PubMed ID: 20103744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of total pancreatectomy on the secretion of gut glucagon in humans.
    Yasui K
    Jpn J Surg; 1983 Mar; 13(2):122-9. PubMed ID: 6350663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EJE PRIZE 2018: A gut feeling about glucagon.
    Knop FK
    Eur J Endocrinol; 2018 Jun; 178(6):R267-R280. PubMed ID: 29678923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incretin physiology beyond glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: cholecystokinin and gastrin peptides.
    Rehfeld JF
    Acta Physiol (Oxf); 2011 Apr; 201(4):405-11. PubMed ID: 21392266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.
    Sonne DP; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Eur J Endocrinol; 2014 Oct; 171(4):407-19. PubMed ID: 24986531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut-hormone profile in totally pancreatectomised patients.
    Dammann HG; Besterman HS; Bloom SR; Schreiber HW
    Gut; 1981 Feb; 22(2):103-7. PubMed ID: 7215941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease.
    Idorn T; Knop FK; Jørgensen M; Holst JJ; Hornum M; Feldt-Rasmussen B
    Kidney Int; 2013 May; 83(5):915-23. PubMed ID: 23325073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactive glucagon and insulin C-peptide in man after resection of the pancreas and total pancreatectomy.
    Kåresen R; Tronier B; Aune S
    Am J Surg; 1980 Aug; 140(2):272-6. PubMed ID: 6996505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
    Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
    Nauck MA; Siemsglüss J; Orskov C; Holst JJ
    Z Gastroenterol; 1996 Mar; 34(3):159-66. PubMed ID: 8650968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
    Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different incretin responses after pancreatoduodenectomy and distal pancreatectomy.
    Mori Y; Ohtsuka T; Tsutsumi K; Yasui T; Ueda J; Takahata S; Nakamura M; Tanaka M
    Pancreas; 2012 Apr; 41(3):455-60. PubMed ID: 22422137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of extrapancreatic immunoreactive glucagon to intraluminal nutrients in pancreatectomized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Horm Metab Res; 1984 Jul; 16(7):344-8. PubMed ID: 6386643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.
    Lund A; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1038-46. PubMed ID: 21386059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.